Vladislav V. Konnov
Research Subjects
Vladislav V. Konnov has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Elena Vasilevna Volchkova
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation
2 shared publications - Nataliya A. Tsvetkova
Infectious Clinical Hospital No. 2, Moscow
2 shared publications - Tatiana V. Kharlamova
RUDN University
2 shared publications - Голуб Вениамин Петрович
People's Friendship University of Russia
2 shared publications A K Tokmalaev
Peoples Friendship University of Russia (RUDN)
1 shared publication- Andrey Nikolaevich Gerasimov
Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical and Biological Agency
1 shared publication
Latest Publications
- Open Access
- 14 December 2025
- Published by ECO-Vector LLC in Epidemiology and Infectious Diseases
- Vol. 30 (3) , 180-193
Predictors of severe COVID-19: older age and comorbidity
BACKGROUND: Older age and comorbidity are recognized as significant risk factors for severe COVID-19. However, the combined impact of these factors on disease outcomes, especially in different age groups, remains unclear. This study focuses on older patients with chronic comorbidities in order to address this gap. AIM: This study aimed to evaluate the role of older age and comorbidities in prediction of severe COVID-19 and mortality in hospitalized patients. METHODS: This cross-sectional, retrospective study included 604 patients aged 18–99 years who were treated at Infectious Diseases Clinical Hospital No. 2 of the Moscow Healthcare Department for laboratory-confirmed (ICD-10 code: U07.1) COVID-19 between September 2020 and November 2022. Demographic characteristics, comorbidities, clinical outcomes (recovery, improvement, and mortality rates), and COVID-19 severity were evaluated. RESULTS: An analysis of 604 hospitalized patients revealed an increase in mortality rates with age: 4.1% in patients under 60 years old, 12.7% in patients aged 60–74 years, 16.4% in patients aged 75–89 years, and 21.9% in patients aged 90 years and older. The most common comorbidity-associated risk factors included chronic kidney disease (mortality rate: 23.2%), myocardial ischemia (19.7%), and type 2 diabetes mellitus (18%). The infection was atypical, without fever in 21% of patients, primarily those in the older age group. Stratified analysis showed that the role of specific risk factors, such as chemotherapy, myocardial ischemia, and chronic kidney disease, varied across age groups. CONCLUSION: Older age and comorbidities are independent risk factors for severe COVID-19 and fatal outcomes. Patients over the age of 75 years with chronic diseases require special attention. Early diagnosis and personalized management strategies may improve outcomes in this age group.
- 14 December 2025
- Published by ECO-Vector LLC in Epidemiology and Infectious Diseases
- Vol. 30 (3) , 180-193
Open AccessPredictors of severe COVID-19: older age and comorbidity
BACKGROUND: Older age and comorbidity are recognized as significant risk factors for severe COVID-19. However, the combined impact of these factors on disease outcomes, especially in different age groups, remains unclear. This study focuses on older patients with chronic comorbidities in order to address this gap. AIM: This study aimed to evaluate the role of older age and comorbidities in prediction of severe COVID-19 and mortality in hospitalized patients. METHODS: This cross-sectional, retrospective study included 604 patients aged 18–99 years who were treated at Infectious Diseases Clinical Hospital No. 2 of the Moscow Healthcare Department for laboratory-confirmed (ICD-10 code: U07.1) COVID-19 between September 2020 and November 2022. Demographic characteristics, comorbidities, clinical outcomes (recovery, improvement, and mortality rates), and COVID-19 severity were evaluated. RESULTS: An analysis of 604 hospitalized patients revealed an increase in mortality rates with age: 4.1% in patients under 60 years old, 12.7% in patients aged 60–74 years, 16.4% in patients aged 75–89 years, and 21.9% in patients aged 90 years and older. The most common comorbidity-associated risk factors included chronic kidney disease (mortality rate: 23.2%), myocardial ischemia (19.7%), and type 2 diabetes mellitus (18%). The infection was atypical, without fever in 21% of patients, primarily those in the older age group. Stratified analysis showed that the role of specific risk factors, such as chemotherapy, myocardial ischemia, and chronic kidney disease, varied across age groups. CONCLUSION: Older age and comorbidities are independent risk factors for severe COVID-19 and fatal outcomes. Patients over the age of 75 years with chronic diseases require special attention. Early diagnosis and personalized management strategies may improve outcomes in this age group.
- Open Access
- 15 June 2020
- Published by ECO-Vector LLC in Epidemiology and Infectious Diseases
- Vol. 25 (3) , 140-152
Trichinosis: outbreak description and brief literature review
Presented here is a description of trichinosis outbreak associated with bear meat consumption in the form of basturma and chips. The clinical, epidemiological, and laboratory characteristics of the disease course in observed three patients are given. In addition, a review of modern literature on the problem of trichinosis is presented, including issues of etiology, epidemiology, developmental cycle of trichinella, and features of disease clinical course, diagnosis, and treatment. Criteria to be looked at when trichinosis is suspected are also discussed.
- 15 June 2020
- Published by ECO-Vector LLC in Epidemiology and Infectious Diseases
- Vol. 25 (3) , 140-152
Open AccessTrichinosis: outbreak description and brief literature review
Presented here is a description of trichinosis outbreak associated with bear meat consumption in the form of basturma and chips. The clinical, epidemiological, and laboratory characteristics of the disease course in observed three patients are given. In addition, a review of modern literature on the problem of trichinosis is presented, including issues of etiology, epidemiology, developmental cycle of trichinella, and features of disease clinical course, diagnosis, and treatment. Criteria to be looked at when trichinosis is suspected are also discussed.
- Open Access
- 20 March 2020
- Published by Bentham Science Publishers Ltd. in The Open AIDS Journal
- Vol. 14 (1) , 11-15
Clinical Assessment of Nutritional and Metabolic Status in HIV Outpatients
Background: After the World Health Organization’s first technical consultation on Nutrient Requirements for People Living with HIV/AIDS in Geneva, 2003, a lot of research questions that are considered crucial for enhancing our understanding of the interaction of nutrition and HIV infection were raised and until this moment, left unanswered. To gain a better understanding of HIV and nutrition, we implemented a comprehensive approach. The aim of our study was to assess the nutritional and metabolic status in order to enhance the provision of medical care to people living with HIV. Methods: 45 HIV patients and 32 healthy volunteers were enrolled in the study. Within the HIV group, 32 (71%) were male and 13 (29%) female. Only 7 (15%) were ART naïve. Overall their median age, CD4 count and viral load were 30 years (IQR: 28-40), 407 (IQR: 357-490) cells/mm3 and 500 (IQR: 0-1000) copies/ml, respectively. None of the participants in the HIV group had any active infection. Food intake by monthly dietary recall was determined. Body composition was measured using bioelectrical impedance analysis. The selected biochemical parameters were evaluated and the resting metabolic rates were calculated using indirect calorimetry to accurately understand the metabolism of participants. Results: Participants in the HIV group did not meet the recommended daily allowance level (RDA) of carbohydrate requirements. The fat-free mass significantly decreased in the HIV group (P < 0.05). Resting energy expenditure was excessive in the HIV group compared to the control group (P < 0.05). Values of urea nitrogen concentration, fat and protein oxidation rates in the HIV group significantly increased (P < 0.01). The carbohydrate oxidation in the HIV group significantly decreased (P < 0.01) Conclusions: The study reveals a catabolic status in the HIV group and suggests an adjustment in the nutrient RDA to compensate such status. Further investigation should be extended to vulnerable population group particularly children.
- 20 March 2020
- Published by Bentham Science Publishers Ltd. in The Open AIDS Journal
- Vol. 14 (1) , 11-15
Open AccessClinical Assessment of Nutritional and Metabolic Status in HIV Outpatients
Background: After the World Health Organization’s first technical consultation on Nutrient Requirements for People Living with HIV/AIDS in Geneva, 2003, a lot of research questions that are considered crucial for enhancing our understanding of the interaction of nutrition and HIV infection were raised and until this moment, left unanswered. To gain a better understanding of HIV and nutrition, we implemented a comprehensive approach. The aim of our study was to assess the nutritional and metabolic status in order to enhance the provision of medical care to people living with HIV. Methods: 45 HIV patients and 32 healthy volunteers were enrolled in the study. Within the HIV group, 32 (71%) were male and 13 (29%) female. Only 7 (15%) were ART naïve. Overall their median age, CD4 count and viral load were 30 years (IQR: 28-40), 407 (IQR: 357-490) cells/mm3 and 500 (IQR: 0-1000) copies/ml, respectively. None of the participants in the HIV group had any active infection. Food intake by monthly dietary recall was determined. Body composition was measured using bioelectrical impedance analysis. The selected biochemical parameters were evaluated and the resting metabolic rates were calculated using indirect calorimetry to accurately understand the metabolism of participants. Results: Participants in the HIV group did not meet the recommended daily allowance level (RDA) of carbohydrate requirements. The fat-free mass significantly decreased in the HIV group (P < 0.05). Resting energy expenditure was excessive in the HIV group compared to the control group (P < 0.05). Values of urea nitrogen concentration, fat and protein oxidation rates in the HIV group significantly increased (P < 0.01). The carbohydrate oxidation in the HIV group significantly decreased (P < 0.01) Conclusions: The study reveals a catabolic status in the HIV group and suggests an adjustment in the nutrient RDA to compensate such status. Further investigation should be extended to vulnerable population group particularly children.
- Open Access
- 15 November 2019
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 91 (11) , 60-65
Human babesiosis: clinical cases in the european part of the Russian Federation
The article describes four clinical observations of patients with babesiosis detected in the European part of the Russian Federation, two of whom were under the direct supervision of the authors. The analysis of epidemiological data, clinical picture, results of laboratory studies in the dynamics of the disease. Differential diagnosis and treatment are discussed.
- 15 November 2019
- Published by Consilium Medicum in Terapevticheskii arkhiv
- Vol. 91 (11) , 60-65
Open AccessHuman babesiosis: clinical cases in the european part of the Russian Federation
The article describes four clinical observations of patients with babesiosis detected in the European part of the Russian Federation, two of whom were under the direct supervision of the authors. The analysis of epidemiological data, clinical picture, results of laboratory studies in the dynamics of the disease. Differential diagnosis and treatment are discussed.